[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 415
Citations 0
Comment & Response
June 28, 2016

Characteristics of Patients Dying With Cancer in Developed Countries—Reply

Carl Rudolf Blankart, PhD1; Ezekiel J. Emanuel, MD, PhD2; Justin E. Bekelman, MD3; et al for the International Consortium for End-of-Life Research
Author Affiliations
  • 1Hamburg Center for Health Economics, University of Hamburg, Hamburg, Germany
  • 2Department of Medical Ethics and Health Policy, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
  • 3Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
JAMA. 2016;315(24):2732. doi:10.1001/jama.2016.4042

In Reply Cross-national comparisons are rare because it is challenging to identify comparable cohorts and data on utilization and costs. Dr Schaefer worries that our study may not be representative. We compared patients dying with cancer using the most comparable cohorts available among nations. We focused on cancer decedents, validating findings from the general cohorts on a more homogeneous cohort, and examining a limited but meaningful set of outcomes available in claims data.

First Page Preview View Large
First page PDF preview
First page PDF preview
×